Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Radiotherapy for hepatocellular carcinomas].
Makishima H, Mizumoto M, Sakurai H. Makishima H, et al. Nihon Shokakibyo Gakkai Zasshi. 2023;120(1):56-61. doi: 10.11405/nisshoshi.120.56. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 36631117 Japanese. No abstract available.
Factors Involved in Preoperative Edema in High-Grade Gliomas.
Saito T, Mizumoto M, Liang HK, Nakai K, Sumiya T, Iizumi T, Kohzuki H, Numajiri H, Makishima H, Tsurubuchi T, Matsuda M, Ishikawa E, Sakurai H. Saito T, et al. Among authors: makishima h. Cureus. 2022 Nov 11;14(11):e31379. doi: 10.7759/cureus.31379. eCollection 2022 Nov. Cureus. 2022. PMID: 36514578 Free PMC article.
Analysis of person-hours required for proton beam therapy for pediatric tumors.
Mizumoto M, Fukushima H, Miyamoto T, Oshiro Y, Sumiya T, Iizumi T, Saito T, Makishima H, Numajiri H, Hosaka S, Nagatomo K, Yamaki Y, Nakai K, Sakurai H. Mizumoto M, et al. Among authors: makishima h. J Radiat Res. 2023 May 25;64(3):599-601. doi: 10.1093/jrr/rrad022. J Radiat Res. 2023. PMID: 37134315 Free PMC article.
Retrospective Analysis of the Areas Responsible for Light Flash and Odor During Proton Beam Therapy and Photon Therapy.
Oshiro Y, Mizumoto M, Miyamoto T, Sumiya T, Fujioka D, Shirataki H, Nakamura M, Ishida T, Iizumi T, Saito T, Numajiri H, Makishima H, Nakai K, Maruo K, Sakae T, Sakurai H. Oshiro Y, et al. Among authors: makishima h. Cureus. 2023 Sep 6;15(9):e44790. doi: 10.7759/cureus.44790. eCollection 2023 Sep. Cureus. 2023. PMID: 37809274 Free PMC article.
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus.
Yanagihara TK, Tepper JE, Moon AM, Barry A, Molla M, Seong J, Torres F, Apisarnthanarax S, Buckstein M, Cardenes H, Chang DT, Feng M, Guha C, Hallemeier CL, Hawkins MA, Hoyer M, Iwata H, Jabbour SK, Kachnic L, Kharofa J, Kim TH, Kirichenko A, Koay EJ, Makishima H, Mases J, Meyer JJ, Munoz-Schuffenegger P, Owen D, Park HC, Saez J, Sanford NN, Scorsetti M, Smith GL, Wo JY, Yoon SM, Lawrence TS, Reig M, Dawson LA. Yanagihara TK, et al. Among authors: makishima h. Pract Radiat Oncol. 2024 Mar-Apr;14(2):134-145. doi: 10.1016/j.prro.2023.08.016. Epub 2024 Jan 19. Pract Radiat Oncol. 2024. PMID: 38244026
Proton Beam Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study in Japan.
Mizumoto M, Terashima K, Makishima H, Suzuki M, Ogino T, Waki T, Iwata H, Tamamura H, Uchinami Y, Akimoto T, Okimoto T, Iizumi T, Murakami M, Katoh N, Maruo K, Shibuya K, Sakurai H. Mizumoto M, et al. Among authors: makishima h. Liver Cancer. 2023 Jul 24;13(2):161-168. doi: 10.1159/000531376. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751552 Free PMC article.
Late Changes in Renal Volume and Function after Proton Beam Therapy in Pediatric and Adult Patients: Children Show Significant Renal Atrophy but Deterioration of Renal Function Is Minimal in the Long-Term in Both Groups.
Li Y, Mizumoto M, Nitta H, Fukushima H, Suzuki R, Hosaka S, Yamaki Y, Murakami M, Baba K, Nakamura M, Ishida T, Makishima H, Iizumi T, Saito T, Numajiri H, Nakai K, Kamizawa S, Kawano C, Oshiro Y, Sakurai H. Li Y, et al. Among authors: makishima h. Cancers (Basel). 2024 Apr 24;16(9):1634. doi: 10.3390/cancers16091634. Cancers (Basel). 2024. PMID: 38730586 Free PMC article.
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.
Usuki K, Miyamoto T, Yamauchi T, Ando K, Ogawa Y, Onozawa M, Yamauchi T, Kiyoi H, Yokota A, Ikezoe T, Katsuoka Y, Takada S, Aotsuka N, Morita Y, Ishikawa T, Asada N, Ota S, Dohi A, Morimoto K, Imai S, Kishimoto U, Akashi K, Miyazaki Y; Study Group for NS-87/CPX-351. Usuki K, et al. Int J Hematol. 2024 Mar 26. doi: 10.1007/s12185-024-03733-z. Online ahead of print. Int J Hematol. 2024. PMID: 38532078
214 results